Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
181.7 USD | -1.12% | +2.45% | +5.78% |
Apr. 17 | Wall St set for higher open on megacaps boost; earnings, Fed comments on tap | RE |
Apr. 01 | Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.78% | 26.99B | |
+7.85% | 220B | |
+6.67% | 185B | |
+10.22% | 133B | |
+26.79% | 107B | |
-0.57% | 62.91B | |
+15.72% | 53.34B | |
-1.89% | 47.71B | |
-2.41% | 40.29B | |
+9.75% | 39.57B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- RBC Downgrades ResMed to Sector Perform From Outperform, Citing Valuation, But Lifts Price Target to $252 From $246, Calls Fiscal Q4 'Solid'